CC
CELG

CQS Cayman’s Celgene Corp CELG Stock Holding History

CQS Cayman’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.54M Sell
15,500
-48,800
-76% -$4.64M 0.07% 131
2019
Q2 		$5.94M Sell
64,300
-97,601
-60% -$9.27M 0.24% 69
2019
Q1 		$15.3M Buy
+161,901
New +$14.2M 0.69% 27
2016
Q4 		– Sell
-3,500
Closed -$366K – 154
2016
Q3 		$366K Buy
+3,500
New +$379K 0.03% 124

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CQS Cayman's CELG Position: Q3 2019 in Review

CQS Cayman reduced its Celgene Corp (CELG) stake by 76% in Q3 2019, selling an estimated $4.64M and leaving 15,500 shares worth $1.54M. The position accounts for 0.07% of the portfolio, ranked #131.

CQS Cayman first reported a position in CELG in Q3 2016 and has held it in 4 quarters since. The position peaked at $15.3M in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • CQS Cayman held 15,500 shares of Celgene Corp worth $1.54M as of Q3 2019.
  • CQS Cayman sold 48,800 Celgene Corp shares in Q3 2019, an estimated $4.64M.
  • Celgene Corp made up 0.07% of CQS Cayman's portfolio in Q3 2019, its #131 holding.
  • CQS Cayman first reported a position in Celgene Corp in Q3 2016 and has held it in 4 quarters since.
  • CQS Cayman's Celgene Corp position peaked at $15.3M in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on CQS Cayman's 13F filing for Q3 2019, filed 12 Nov 2019.